Health & Medicine

STAT+: Pharmalittle: We're reading about a Supreme Court hearing on 'skinny labels,' AstraZeneca U.K. expansion, and more

22 sec read79 views0 listens

AstraZeneca is investing $400 million to expand its R&D operations in Cambridge, U.K., following a trade deal that eased tensions over medicine spending. This move signals renewed confidence from pharmaceutical giants in U.K. investments post-trade agreement, potentially paving the way for further tech and data-driven advancements in drug development.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Legal & Policy13 hours ago30 sec read

The Mail-In Ballot Fight Is Right Back Where It Started, With The Trump Administration Taking Another 'L'

A U.S. district court has granted a temporary restraining order against a new USPS rule requiring states to submit ballot-envelope designs for federal approval, halting implementation of the regulation ahead of the November election. This decision is...

Ali Nemati

Legal & Policy1 day ago26 sec read

What the public thinks of the Supreme Court

The Marquette Law School Poll reveals a 47% approval rating for the Supreme Court, with significant partisan divides: 74% of Republicans approve compared to only 22% of Democrats. Public perception of the court's alignment with President Trump also v...

Ali Nemati

Legal & PolicyAug 124 sec read

This Week In Techdirt History: July 26th - August 1st

TechDirt highlights key tech and legal developments from July 26th to August 1st, including discussions on Russian hacking of the DNC, Verizon's acquisition of Yahoo, and copyright issues affecting content creators and users. These topics are crucial...

Ali Nemati